Novo Nordisk initiates share repurchase
- Share repurchase program started on 6 May 2026
- Up to DKK 11.2 billion for B shares until 1 Feb 2027
- Repurchased 23,090,000 B shares as of 9 Oct 2026
NVO
NOVO NORDISK A S SEC filings
Every EDGAR filing for NOVO NORDISK A S (NVO), newest first, with AI summaries and stories.
- Ticker
- NVO
- CIK
- 353278
- Latest filing
- 6d
Filings
6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE NOVO NORDISK A S initiates share repurchase
- Share repurchase program up to DKK 15 billion
- Repurchased B shares worth DKK 6.4 billion as of 2 October 2026
- Owns 1.1% of share capital as treasury shares
6-KNOVO NORDISK A SNONOFLIVE Novo Nordisk updates on denecimig BLA review
- FDA says BLA review for denecimig is ongoing
- FDA cites facility remediation as reason for delay
- No impact on 2026 financial outlook
6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE SCHEDULE 13G/AInnate Pharma SAIPHYFLIVE Ownership stake disclosure by Nordisk A S Novo (amended)
Nordisk A S Novo, filed by
6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE SDNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE SCHEDULE 13G/AInnate Pharma SAIPHYFLIVE Ownership stake disclosure by Nordisk A S Novo (amended)
Nordisk A S Novo, filed by
6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNONOFLIVE 6-KNOVO NORDISK A SNVOLIVE 6-KNOVO NORDISK A SNVOLIVE SCHEDULE 13G/AInnate Pharma SAIPHYFLIVE Ownership stake disclosure by Nordisk A S Novo (amended)
Nordisk A S Novo, filed by